Trial Profile
A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Mar 2024
Price :
$35
*
At a glance
- Drugs Indimitecan (Primary) ; Indotecan (Primary)
- Indications Adenocarcinoma; Adrenocortical carcinoma; Bladder cancer; Breast cancer; Colorectal cancer; Head and neck cancer; Hodgkin's disease; Lymphoma; Male breast cancer; Malignant melanoma; Non-Hodgkin's lymphoma; Non-small cell lung cancer; Ovarian cancer; Pancreatic cancer; Parotid cancer; Renal cell carcinoma; Sarcoma; Small cell lung cancer; Solid tumours; Thyroid cancer; Vulvovaginal cancer
- Focus Adverse reactions; First in man
- 22 Jun 2017 Status changed from active, no longer recruiting to completed.
- 22 Jun 2017 Status changed from active, no longer recruiting to completed.
- 02 Jun 2017 Results (n=34) assessing safety and tolerability of LMP776 in patients with with relapsed solid tumors and lymphomas, presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.